Previous studies on different animal species have found that vitamin C significantly prevents and alleviates infections caused by diverse bacteria, viruses and protozoa.
Given the universal nature of the effect of vitamin C against various infections in different animal species, it also seems evident that vitamin C influences the susceptibility to, and the severity of infections in humans.
The common cold is the most extensively studied infection regarding the effects of vitamin C. The majority of controlled trials have used a modest dosage of only one gramme per day of vitamin C.
However, the optimal doses and the maximal effects of vitamin C on the common cold are unknown.
Harri Hemila from the University of Helsinki in Finland, analysed the findings of two randomised trials each of which investigated the effects of two vitamin C doses on the duration of the common cold.
The first trial administered three grammes per day vitamin C to two study groups, six grammes per day to a third group, and the fourth group was administered a placebo.
The second trial administered four grammes per day and eight grammes per day vitamin C, and placebo to different groups, but only on the first day of the cold.
Compared with the placebo group, the eight grammes per day dose shortened colds by 19 per cent, twice as much as the four grammes per day dose did.
Both studies showed a significant dose-response relationship between the vitamin C dosage and the duration of the common cold.
Hemila noted that there have been proposals that vitamin C doses should be over 15 grammes per day for the best treatment of colds, but the highest doses that have so far been investigated in randomised trials have been much lower.
"Given the consistent effect of vitamin C on the duration of colds, and its safety and low cost, it would be worthwhile for individual common cold patients to test whether therapeutic eight grammes per day vitamin C is beneficial for them," Hemila said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
